Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
07/1996
07/02/1996US5532214 Anti-HIV protein, TAP 29, from tricosanthes, DNA coding therefor and therapeutic uses thereof
07/02/1996US5532152 Platelet-activating factor acetylhydrolase
07/02/1996CA2078347C Use of copper(ii) containing compounds to accelerate wound healing
06/1996
06/30/1996CA2166234A1 3-phenylisoquinol-1(2h)-one derivatives, their preparation and their therapeutic application
06/29/1996CA2166168A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition
06/29/1996CA2166165A1 Substituted 4-phenylthiazole derivatives, process for their preparation and pharmaceutical compositions containing them
06/27/1996WO1996019580A2 Telomerase protein component
06/27/1996WO1996019574A1 Human interleukin-11 receptor
06/27/1996WO1996019566A1 E2 binding proteins
06/27/1996WO1996019477A1 Tetracyclic spiro compounds, process for their preparation and their use as 5ht1d receptor antagonists
06/27/1996WO1996019474A1 Quinazolines as inhibitors of endothelin converting enzyme
06/27/1996WO1996019469A1 Diaryl-2-(5h)-furanones as cox-2 inhibitors
06/27/1996WO1996019463A1 Heteroaromatic oxazole compounds and use thereof
06/27/1996WO1996019462A1 Oxazole derivatives and use thereof
06/27/1996WO1996019455A1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
06/27/1996WO1996019451A1 Substituted azetidin-2-ones for treatment of atherosclerosis
06/27/1996WO1996019440A1 Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase
06/27/1996WO1996019246A1 Continuous low-dose administration of parathyroid hormone or its agonist
06/27/1996WO1996019226A1 Combination chemotherapy of suramin and a vinca-alkaloid or estramustine
06/27/1996WO1996019224A1 Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
06/27/1996WO1996019209A1 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours
06/27/1996WO1996019208A1 Use of a vitamin of the k group for treating hyperparathyroidism
06/27/1996WO1996019206A1 Therapeutic preparation for inhalation containing parathyroïd hormone, pth
06/27/1996WO1996015786A3 Oral compositions containing ondansetron
06/27/1996DE4446024A1 Verwendung eines Vitamins der K-Gruppe Use of a vitamin K-Group
06/27/1996CA2341921A1 Amide compounds intermediates
06/27/1996CA2208530A1 Substituted azetidin-2-ones for treatment of atherosclerosis
06/27/1996CA2208485A1 Method for protecting the heart from ischemia
06/27/1996CA2208457A1 Human interleukin-11 receptor
06/27/1996CA2208316A1 Oxazole derivatives and use thereof
06/27/1996CA2208244A1 Tetracyclic spiro compounds, process for their preparation and their use as 5ht1d receptor antagonists
06/27/1996CA2208211A1 E2-binding proteins
06/27/1996CA2208011A1 Aryl-and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
06/27/1996CA2206978A1 Diaryl-2-(5h)-furanones as cox-2 inhibitors
06/27/1996CA2206112A1 Combination chemotherapy of suramin and a vinca-alkaloid or estramustine
06/27/1996CA2206046A1 Quinazolines as inhibitors of endothelin converting enzyme
06/27/1996CA2205959A1 Continuous low-dose administration of parathyroid hormone or its agonist
06/27/1996CA2183645A1 Heterocyclic aromatic oxazole compounds and use thereof
06/26/1996EP0718299A1 Tricyclic oxime ethers process for their preparation and pharmaceutical compositions containing them
06/26/1996EP0718297A1 Pyrazine derivatives as muscarinic receptor agonists
06/26/1996EP0718295A1 Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis
06/26/1996EP0718294A1 2-Amino-1,3-thiazepines and their use as inhibitors of the nitrogene oxide synthase
06/26/1996EP0718287A2 Piperazine derivatives, medicaments containing them, their use, and processes for their preparation
06/26/1996EP0718286A1 3-Alkoxybenzylpiperidine derivatives as melatonergic agents
06/26/1996EP0717995A2 Cell degeneration suppressing and organ toxicity reducing agent
06/26/1996EP0717984A2 Lactate dehydrogenase inhibitors in cosmetic compositions
06/26/1996EP0717983A1 Cosmetic compositions containing betulinic acid
06/26/1996EP0717750A1 Double-stranded peptide nucleic acids
06/26/1996EP0717742A1 Process for the preparation of indolizine derivatives
06/26/1996EP0717739A1 Bicyclic aromatic compounds as therapeutic agents
06/26/1996EP0717733A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
06/26/1996EP0717731A1 Difluoro statone antiviral analogs
06/26/1996EP0717635A1 Methods for regulating gastrointestinal motility
06/26/1996EP0717624A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
06/26/1996EP0717619A1 Treatment of adverse effects associated with administration of extracellular hemoglobin
06/26/1996EP0717616A1 Process for conditioning substances
06/26/1996EP0697859A4 Stable, ingestable and absorbable nadh and nadph therapeutic compositions
06/26/1996CN1125445A Novel chemical compounds having PDE-IV inhibition activity
06/26/1996CN1125442A Imidazole lipoxygenase inhibitors
06/26/1996CN1125436A Vitamin D amide derivatives
06/26/1996CN1125402A Potassium channel blocking compounds and their use
06/26/1996CN1125399A Immunogenic cancer proteins and peptides and method of use
06/26/1996CN1125396A Extended release, film-coated tablet of astemizole and pseudoephedrine
06/26/1996CN1032135C 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(RS) derivatives with properties of mucus-adjustment and antiischemia
06/25/1996US5530128 Enzyme inhibitor as antitumor agent
06/25/1996US5530114 Oligonucleotide modulation of arachidonic acid metabolism
06/25/1996US5530109 DNA encoding glial mitogenic factors
06/25/1996US5530096 Diagnosis and therapy of tumors, autoimmune diseases
06/25/1996US5530019 For treatment of prostate gland disorders
06/25/1996US5530017 Method of antagonizing angiotensin II receptors in mammals using substituted [1H-Imidazol-5-YL] alkenoic acids
06/25/1996US5530012 3-alkoxybenzylpiperidine derivatives as melatonergic agents
06/25/1996US5530009 Treating asthma
06/25/1996US5529996 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
06/25/1996US5529995 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ACE
06/25/1996US5529991 Oral 1α-hydroxyprevitamin D
06/25/1996US5529792 Homogenizing chicken embryo or adult bovine brain tissue, centrifuging, applying to cation exchanger, separating active fractions by gel filtration chromatography, purifying by reverse phase liquid chromatography
06/25/1996US5529790 Delayed, sustained-release diltiazem pharmaceutical preparation
06/25/1996US5529769 Cosmetic compositions containing betulinic acid
06/24/1996CA2165922A1 Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation
06/23/1996CA2165603A1 3-alkoxybenzylpiperidine derivatives as melatonergic agents
06/22/1996CA2165751A1 Quinuclidine and azabicyclo¬2.2.1|heptane pyrazinyl ethers as muscarinic agonists
06/20/1996WO1996018725A1 Human tissue inhibitor of metalloproteinase-4
06/20/1996WO1996018650A1 Novel receptor
06/20/1996WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
06/20/1996WO1996018644A1 Aromatic heterocyclic derivatives as enzyme inhibitors
06/20/1996WO1996018639A1 Novel protein tyrosine kinase, jak3
06/20/1996WO1996018626A1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
06/20/1996WO1996018615A1 Polyarylcarbamoylaza -and- carbamoylalkanedioic acids
06/20/1996WO1996018413A1 Carcinoma treatment
06/20/1996WO1996018412A1 Chimeric cytokines and uses thereof
06/20/1996WO1996018411A1 Localized delivery of factors enhancing survival of transplanted cells
06/20/1996WO1996018404A1 Sphingosine, methylsphingosine and apoptosis
06/20/1996WO1996018403A1 Combined use of diclofenac and tribenoside to treat osteoarthritis
06/20/1996WO1996018402A1 Cobalt schiff base compounds
06/20/1996WO1996018401A1 Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound
06/20/1996WO1996018399A1 Aryl thioxanthines
06/20/1996WO1996018393A1 Novel compounds
06/20/1996WO1996018392A1 Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds
06/20/1996WO1996018391A2 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
06/20/1996WO1996018382A1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
1 ... 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 ... 1564